Global Research

Global Research in the Middle East and North Africa

The Middle East and North Africa region faces many challenges, including instability and disparate economic performance, both of which have adverse effects on health and survival. Disruptions in health care, access to clean water, and sanitation are problems in the region.

NIAID’s research priorities in the MENA region include antimicrobial resistance and immunodeficiency diseases, with continuing interest in research on neglected tropical diseases such as cutaneous leishmaniasis, which is on the rise due to favorable growth of the sandfly vector. NIAID is also significantly involved in research on other infectious diseases in​ the region, including Middle East respiratory syndrome coronavirus (MERS-CoV) and hepatitis C, B, and D.

Countries With NIAID-Funded Activities (Fiscal Year 2022)

  • Egypt
  • Israel
  • Jordan
  • Kuwait
  • Lebanon
  • Morocco
  • Saudi Arabia
  • Sudan
  • Tunisia
  • United Arab Emirates

Disclaimer: This is a Google map, not a NIAID generated map and as such it may not accurately represent the current policy followed by the U.S. Government regarding country sovereignty boundaries.

View Larger Map
 

Highlights

NIAID-Middle East, North Africa, and Turkey (MENAT) Strategy for Enhanced Research Engagement

Learn more about NIAID's FY2020 international research activities in the Middle East and North Africa region in this Fact Sheet.

For more information about NIAID-funded activities in the Middle East and North Africa region, please email NIAIDOGRAMEE@mail.nih.gov.

Content last reviewed on